First European advice launched for deadly acute heart failure
Death risk higher than heart attack but care lags 30 years behind
Embargo: 22 February 2016 at 01:15 CET
Sophia Antipolis, 22 February 2016: The first European advice on emergency care for patients with acute heart failure is published today in European Heart Journal: Acute Cardiovascular Care.1 Acute heart failure carries a higher risk of death than heart attack but care lags 30 years behind.
“Only half of patients discharged with acute heart failure are alive in three years.”
“Mortality from acute heart failure is even higher than from a heart attack so it is an urgent situation,” said Professor Christian Mueller, chair of the Acute Heart Failure Study Group of the Acute Cardiovascular Care Association (ACCA) of the European Society of Cardiology (ESC).
“Only half of patients discharged from hospital with acute heart failure are alive in three years, even though they felt fine,” he continued. “Despite the severity of the condition there are no standard treatment pathways, whereas these were agreed across Europe for heart attack 30 years ago. The paper published today is the first step towards catching up with heart attack care and establishing similar standards for acute heart failure.”
Acute heart failure is a chronic disorder that flares up and leads to emergency visits. The vast majority of patients present to an emergency department with sudden and severe shortness of breath (called acute dyspnoea) at rest. In 50% of patients the underlying condition is chronic heart failure. The other 50% could have had a heart attack ten years ago, or their underlying heart condition is undiagnosed.
“Most patients with acute heart failure cannot be cured,” said Professor Mueller. “We can effectively treat the acute flare ups of dyspnoea with vasodilators or diuretics that remove the extra fluid on the lungs. But the underlying progressive disease remains and patients need long term follow up to make sure they are on the correct medication at the right dosages.”
The paper published today focuses on the pivotal decision of whether to discharge patients with acute heart failure from the emergency department and see them as outpatients, or to admit them to hospital. Until now there was no guidance on this issue. The result is that emergency physicians have tended to act conservatively and admit patients to hospital.
“The hospital is not always the best place to care for acutely ill patients,” said Professor Mueller. “While in hospital, patients with acute heart failure – who are 78 years old on average - are at risk of developing infections and they have problems sleeping. There is also pressure on hospitals to avoid expensive admissions when possible. But patients do benefit from more intense follow up while in hospital.”
The paper outlines criteria to help clinicians select patients that can be safely discharged from the emergency department. A novel algorithm shows the order of decisions to be made and what to consider at each step.
Professor Mueller said: “The paper aims to kick start the process of emergency medicine physicians and cardiologists joining forces to apply or adjust the algorithm so that it works locally. The patient pathway and decisions on place of treatment will vary depending on reimbursement policies and logistics.”
The importance of long term follow up is emphasised, regardless of whether patients are discharged directly from the emergency department or spend a period in hospital before being sent home. Follow up planning should be done by the emergency team in collaboration with the general practitioner (GP), cardiologist, and others involved in the patient’s long term care.
“It’s never ever possible to treat acute heart failure sufficiently in 24 hours in the emergency department,” said Professor Mueller. “Intense follow up will always be needed. It’s the task of the emergency department physician to either make the first follow up appointment or to ensure that this will occur. Patients should be seen by their GP within 48 hours to fine tune the number of drugs and their doses, and assess vital signs, blood pressure, electrolytes and kidney function.”
He concluded: “Ultimately we hope this guidance will improve the management of patients with acute heart failure and make some inroads towards giving them a better outlook.” ENDS
SOURCES OF FUNDING: This work was supported by the Instituto de Salud Carlos III supported with funds from the Spanish Ministry of Health and FEDER (grants numbers PI15/01019, PI15/00773 and PI11/01021), La Marató de TV3 (2005), and the National Institutes of Health/National Heart, Lung and Blood Institute (grant number 1-K23-HL123533-01A1). Emergencies: Processes and pathologies research group of the IDIBAPS receives financial support from the Catalonia Govern for Consolidated Groups of Investigation (grant numbers GRC 2009/1385 and 2014/0313).
DISCLOSURES: Please see the full paper for disclosures of all authors.
Reference
1Miró Ò, Peacock FW, McMurray JJ, Bueno H, Christ M, Maisel AS, Cullen L, Cowie MR, Di Somma S, Martín Sánchez FJ, Platz E, Masip J, Zeymer U, Vrints C, Price S, Mebazaa A, Mueller C. European Society of Cardiology – Acute Cardiovascular Care Association position paper on safe discharge of acute heart failure patients from the emergency department. European Heart Journal: Acute Cardiovascular Care. DOI: 10.1177/2048872616633853
About European Heart Journal: Acute Cardiovascular Care
The European Heart Journal: Acute Cardiovascular Care is the official peer-reviewed Journal of the Acute Cardiovascular Care Association of the European Society of Cardiology.
About the Acute Cardiovascular Care Association
The Acute Cardiovascular Care Association (ACCA) is a registered branch of the ESC. Its mission is to improve the quality of care and outcomes of patients with acute cardiovascular diseases.
Authors
ESC Press Office
press@escardio.org
+33 4 92 94 86 27
European Society of Cardiology
The European Society of Cardiology (ESC) represents more than 95 000 cardiology professionals across Europe and the Mediterranean. Its mission is to reduce the burden of cardiovascular disease in Europe.